MX2011004058A - Deteccion de acido nucleico de npm1 en fluidos corporales carentes de celulas. - Google Patents

Deteccion de acido nucleico de npm1 en fluidos corporales carentes de celulas.

Info

Publication number
MX2011004058A
MX2011004058A MX2011004058A MX2011004058A MX2011004058A MX 2011004058 A MX2011004058 A MX 2011004058A MX 2011004058 A MX2011004058 A MX 2011004058A MX 2011004058 A MX2011004058 A MX 2011004058A MX 2011004058 A MX2011004058 A MX 2011004058A
Authority
MX
Mexico
Prior art keywords
npm1
nucleic acid
mutations
mutation
individual
Prior art date
Application number
MX2011004058A
Other languages
English (en)
Spanish (es)
Inventor
Maher Albitar
Original Assignee
Quest Diagnostics Invest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Inc filed Critical Quest Diagnostics Invest Inc
Publication of MX2011004058A publication Critical patent/MX2011004058A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2011004058A 2008-10-17 2009-10-14 Deteccion de acido nucleico de npm1 en fluidos corporales carentes de celulas. MX2011004058A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10653208P 2008-10-17 2008-10-17
US11094108P 2008-11-03 2008-11-03
US12/336,475 US20100099084A1 (en) 2008-10-17 2008-12-16 Detection of npm1 nucleic acid in acellular body fluids
PCT/US2009/060672 WO2010045354A1 (en) 2008-10-17 2009-10-14 Detection of npm1 nucleic acid in acellular body fluids

Publications (1)

Publication Number Publication Date
MX2011004058A true MX2011004058A (es) 2011-08-12

Family

ID=42106876

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011004058A MX2011004058A (es) 2008-10-17 2009-10-14 Deteccion de acido nucleico de npm1 en fluidos corporales carentes de celulas.

Country Status (8)

Country Link
US (1) US20100099084A1 (ja)
EP (1) EP2337867A4 (ja)
JP (1) JP2012505655A (ja)
CN (1) CN102186995A (ja)
BR (1) BRPI0920695A2 (ja)
CA (1) CA2740230A1 (ja)
MX (1) MX2011004058A (ja)
WO (1) WO2010045354A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101955994B (zh) * 2010-06-17 2013-01-23 江苏迈迪基因生物科技有限公司 Npm1基因突变的联合检测方法及诊断试剂盒
WO2012071411A2 (en) * 2010-11-22 2012-05-31 Innate Pharma Sa Nk cell modulating treatments and methods for treatment of hematological malignancies
KR101660322B1 (ko) * 2011-04-28 2016-09-29 아크레이 가부시키가이샤 ＮＰＭ1 유전자의 ｅｘｏｎ12 변이의 검출용 프로브 및 그 용도
GB201116131D0 (en) * 2011-09-19 2011-11-02 Epistem Ltd Probe
CN103103251A (zh) * 2011-11-15 2013-05-15 中山大学达安基因股份有限公司 荧光pcr毛细管电泳检测flt3-itd基因突变的试剂盒
CN102382896A (zh) * 2011-12-06 2012-03-21 苏州苏大赛尔免疫生物技术有限公司 Npm1基因突变检测方法及其试剂盒
CN107613969B (zh) 2015-03-31 2022-07-22 希洛斯医药品股份有限公司 对使用维甲酸受体-α激动剂治疗的患者进行分层的方法
US9868994B2 (en) 2016-04-08 2018-01-16 Syros Pharmaceuticals, Inc. Methods of stratifying patients for treatment with retinoic acid receptor-α agonists
CN110408697A (zh) * 2016-07-08 2019-11-05 中山大学达安基因股份有限公司 Npm1基因突变分型检测方法及试剂盒
WO2019195975A1 (zh) * 2018-04-09 2019-10-17 深圳华大生命科学研究院 基因文库的构建方法及其应用
CN110669840B (zh) * 2019-10-30 2021-03-19 宁波胤瑞生物医学仪器有限责任公司 一种npm1突变检测试剂盒
CN113637751A (zh) * 2021-07-16 2021-11-12 暨南大学 Tnfaip3非编码序列突变检测试剂在制备预测t细胞淋巴瘤预后试剂盒中的应用
CN117795091A (zh) * 2021-08-05 2024-03-29 香港大学 用于快速多重筛选和监测npm1突变的组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001230A (en) * 1988-04-29 1999-12-14 Beckman Coulter, Inc. Automated capillary electrophoresis apparatus
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
US5223391A (en) * 1990-02-21 1993-06-29 President And Fellows Of Harvard College Inhibitors of herpes simplex virus replication
CA2094343A1 (en) * 1992-07-17 1994-01-18 Gerald L. Klein Method and apparatus for displaying capillary electrophoresis data
US6217731B1 (en) * 1998-10-21 2001-04-17 Spectrumedix Corporation Method and apparatus for monitoring and displaying the status of a parallel capillary electrophoresis device
JP2007236253A (ja) * 2006-03-07 2007-09-20 Toray Ind Inc 疾患又は疾患マーカーの検出方法
US20070248961A1 (en) * 2006-04-20 2007-10-25 Maher Albitar Methods for detecting mutations in JAK2 nucleic acid

Also Published As

Publication number Publication date
BRPI0920695A2 (pt) 2016-01-12
US20100099084A1 (en) 2010-04-22
CN102186995A (zh) 2011-09-14
WO2010045354A1 (en) 2010-04-22
CA2740230A1 (en) 2010-04-22
JP2012505655A (ja) 2012-03-08
EP2337867A1 (en) 2011-06-29
EP2337867A4 (en) 2012-10-24

Similar Documents

Publication Publication Date Title
MX2011004058A (es) Deteccion de acido nucleico de npm1 en fluidos corporales carentes de celulas.
US11021758B2 (en) Methods for detecting gene dysregulation by intragenic differential expression
US10487367B2 (en) Detection of gene fusions by intragenic differential expression (IDE) using average cycle thresholds
US20070020657A1 (en) Methods for detecting circulating tumor cells
CN116064796A (zh) 通过分析甲基化dna来检测肺肿瘤
BR112021009795A2 (pt) métodos de caracterização e para caracterizar uma amostra, kit e composição
CA2569502A1 (en) Diagnosing or predicting the course of breast cancer
KR20210119474A (ko) 자궁내막암 검출
JP2022546504A (ja) 肺新生物形成を有する疑いのある対象におけるメチル化されたｄｎａ、ｒｎａ、及びタンパク質の特性決定
US20130288236A1 (en) Wt1 mutations for prognosis of myeloproliferative disorders
EP2770066B1 (en) Compositions and methods for detecting mutations in JAK2 nucleic acid
WO2009062078A1 (en) Jak2 mutations
MX2007013726A (es) Metodos y equipos para el analisis del efecto de campo en el cancer de prostata.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal